Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2011; 17(46): 5035-5048
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5035
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5035
GI pathogenesis | Disorder |
Peripheral neurotoxine action | Interstitial cells of Cajal involvement[18] |
GI flora? Neurotropic viral pathogen | GI disorders[19] |
GI flora? Helicobacter pylori | Modified l-dopa pharmacokinetics[102] |
GI dysmotility: Early lesions in the enteric nervous system | GI dysfunction[11,163] |
GI dysmotility: Disruption in parts of the CNS | Neurogenic dysphagia[54] |
GI dysmotility: Lewy bodies in esophageal myenteric plexuses | Manometric abnormalities[97,98] |
GI dysmotility: Reduction amplitude of peristaltic contractions | Decreased gastric motility[105] |
GI dysmotility: Gastric pacemaker disturbances | Gastric dysrhythmias[106] |
GI dysmotility: Loss of enteric dopaminergic neurons | Changes in colon motility[173] |
Neurotransmitter dysfunction: Altered enteric nitrergic systems | Disturbed distal gut transit[95] |
Neurohormone involvement: Neurotensin | GI disorders[103] |
Levodopa | Altered oral phase of deglutition[96] |
Monoamine dysfunction | Nonmotor symptoms[176] |
- Citation: Awad RA. Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson’s disease. World J Gastroenterol 2011; 17(46): 5035-5048
- URL: https://www.wjgnet.com/1007-9327/full/v17/i46/5035.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i46.5035